This Solicitation opportunity from Department Of Defense was posted on May 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

FUROSEMIDE INJECTIO

Closed

SPE2DP-26-T-3579Federal

Submission Closed06/03/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supply of PYP Cold VialsThe contract involves the supply of PYP cold vials to the VA Pittsburgh facility, requiring a stringent same-day delivery service within a 2-hour window during business hours. The supplier must ensure the maintenance of the cold chain throughout the delivery process, complying with all relevant regulatory standards to preserve the integrity of the product. This contract is categorized under NAICS code 325412 and is managed by the Department of Veterans Affairs, specifically through the 244-NETWORK Contract Office 4. Responses to this subcontract opportunity must be submitted by July 10, 2026. The contract emphasizes urgency and precision in delivery, reflecting the critical nature of the supplies for the facility's operations. The detailed logistics and regulatory compliance underscore the importance of reliability and quality control in fulfilling the contract requirements. Information about the contract was made available as of June 12, 2026.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

PETNET PharmaceuticalThe Medical Readiness Contracting Office-West plans to award a firm fixed-price sole source contract to PETNET Solutions INC., doing business as Siemens Healthineers, for the supply of FDA-approved radiopharmaceuticals including FDG, NaF, Amyvid, and Posluma. The contract encompasses a base period from October 1, 2026, to September 30, 2027, with an option period extending to September 30, 2028. This contract will be executed under statutory authority FAR 12.102(a), allowing for non-competitive procurement due to the determination that only one source is reasonably available to meet the government's specific needs. The contract falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. The delivery location for the products will be the William Beaumont Army Medical Center at Fort Bliss, Texas. The notice explicitly states that no competitive proposals will be solicited, and the government will not honor any capability briefings or telephonic inquiries related to this contract. The point of contact for inquiries is Darryl O. Bryant, with a secondary contact being Karina Haddix, both representatives of the Department of Defense’s Medical Readiness Contracting Office-West.

W40M MRC0 West

POSTED

5 days ago

DEADLINE

in 6 days

AI Contract Overview

This contract pertains to the procurement of Furosemide Injection, USP, specifically a pharmaceutical product used for intravenous and intramuscular administration. Each vial contains 2 mL of a clear, colorless, preservative-free solution with 10 mg of Furosemide per mL. The product is supplied in packages containing 25 single-dose vials, with a total shelf life of 24 months, and requires at least 21 months of remaining shelf life upon receipt by the government. Storage conditions mandate controlled room temperature between 20° and 25°C, with allowable excursions between 15° and 30°C, and protection from light. The labeling and packaging must comply with Medical Marking Standard No.1A and DLA packaging requirements, ensuring safe delivery and damage prevention during transportation. The product is latex-free, non-DEHP, and mercury or mercury-containing compounds are prohibited in related hardware or supplies except in designated exceptions. The contract is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA and requires delivery within five days to a specified FPO address associated with the USS Hopper (DDG 70). Inspection and acceptance are conducted at the destination. Packaging must adhere to commercial standards and applicable government and FDA regulations, including those governing hazardous materials if relevant. The solicitation was posted in May 2026 with a response deadline in early June 2026, and detailed technical and quality requirements refer to DLA’s master lists that supersede standard packaging guidelines. The contract references specific manufacturers and part numbers, ensuring traceability and regulatory compliance for this controlled medical pharmaceutical acquisition.

General Info

Procurement of Furosemide Injection, 25 vials/package, 10 mg/mL, 24-month shelf life, DoD delivery.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 100182 BOX 1, FPO, AP, 96667, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3579 Medical Supply Chain Pharma FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedMay 28

Solicitation

Amendment 1May 28

Contract was updated

Response DeadlineJun 3

Deadline has passed

Submission Closed

06/03/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

MEGHAN SMINK

contact@example.gov

+1 (555) 000-0000

Full Description

FUROSEMIDE INJECTIO
FUROSEMIDE INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY, LATEX-FREE, NON-DEHP,
PRESERVATIVE-FREE
.
FOR INTRAVENOUS AND INTRAMUSCULAR INJECTION
.
EACH ML CONTAINS: FUROSEMIDE USP 10 MG
.
VIAL VOLUME: 2 ML
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
25 SINGLE DOSE VIALS
.
TOTAL SHELF LIFE IS 24 MONTHS.
.
THERE SHALL BE A MINIMUM OF 21 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF
RECIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT CONTROLLED ROOM TEMPERATURE
20° TO 25°C (68° TO 77°F).
.
EXCURSIONS PERMITTED TO 15° TO 30°C (59° TO 86°F)
(SEE USP CONTROLLED ROOM TEMPERATURE).
.
USE ONLY IF THE SOLUTION IS CLEAR AND COLORLESS
DO NOT USE IF SOLUTION IS DISCOLORED.
.
PROTECT FROM LIGHT.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
5/20/2015
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
SPE2DP-26-T-3579
SECTION B
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
FRESENIUS KABI, LLC 57KZ6 P/N 28002 FRESENIUS KABI, LLC 57KZ6 P/N NDC63323-0280-02 HOSPIRA WORLDWIDE LLC 72QE3 P/N NDC00409-6102-02
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016946406 0001 PG 1.000
NSN/MATERIAL:6505011575117
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
SPE2DP-26-T-3579
SECTION B
PR: 7016946406 PRLI: 0001 CONT’D
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21944
USS HOPPER DDG 70
UNIT 100182 BOX 1
FPO AP 96667
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21944
USS HOPPER DDG 70
DLA VENDORS: USE VSM FOR
US
RDD 999/NMCS SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R219445241HM32
RDD: 999
PROJ: E5K TP 1
SUPP ADD: YNHM01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:09/09/2025
SPE2DP-26-T-3579 NSN/Part Number: 6505-01-157-5117 Quantity: 1 PG Purchase Request: 7016946406QTY: 1 Delivery: 5 days ADO